Definitive Healthcare Corp. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
25 Junio 2024 - 5:57PM
Definitive Healthcare (Nasdaq: DH), an industry leader in
healthcare commercial intelligence, today announced that Definitive
Healthcare’s Board of Directors (the “Board”) granted inducement
awards consisting of 1,137,038 performance-based restricted stock
units (“PSUs”) and 1,170,047 time-based restricted stock units
(“RSUs”) to Kevin Coop, Definitive Healthcare’s new Chief Executive
Officer and member of the Board, effective June 24, 2024. The
awards were granted as an inducement material to Mr. Coop’s
commencement of employment with Definitive Healthcare in accordance
with Nasdaq Listing Rule 5635(c)(4).
The awards are subject to the terms and conditions of Definitive
Healthcare’s 2023 Inducement Plan (the “Plan”) and the terms and
conditions of the applicable award agreement covering the grant.
One fourth of the shares underlying the RSUs vest on July 1, 2025,
with the remaining shares vesting in 12 equal quarterly
installments thereafter. The PSUs are divided into four vesting
tranches, as follows: (i) 200,000 PSUs are subject to the first
vesting tranche, (ii) 266,667 PSUs are subject to the second
vesting tranche, (iii) 300,000 PSUs are subject to the third
vesting tranche, and (iv) 370,371 PSUs are subject to the fourth
vesting tranche. The first vesting tranche will vest during a
two-year performance period beginning on the grant date and the
other three vesting tranches will vest during a four-year
performance period beginning on the grant date (each, a
“Performance Period”). The PSUs become earned based on achievement
of certain stock price hurdles and shall vest upon the Human
Capital Management and Compensation Committee’s certification of
the achievement of the stock price hurdle for the applicable
vesting tranche and Performance Period, subject to Mr. Coop’s
continued service (as defined in the Plan) through the date of such
certification.
About Definitive
Healthcare
At Definitive Healthcare, our passion is to transform data,
analytics and expertise into healthcare commercial intelligence. We
help clients uncover the right markets, opportunities and people,
so they can shape tomorrow’s healthcare industry. Our SaaS platform
creates new paths to commercial success in the healthcare market,
so companies can identify where to go next. Learn more at
definitivehc.com.
Investor Relations
Contact:Brian DenyeauICR for Definitive
Healthcarebrian.denyeau@icrinc.com
Media Contacts: Bethany Swackhammer
bswackhamer@definitivehc.com
Definitive Healthcare (NASDAQ:DH)
Gráfica de Acción Histórica
De Ago 2024 a Sep 2024
Definitive Healthcare (NASDAQ:DH)
Gráfica de Acción Histórica
De Sep 2023 a Sep 2024